FDA Inspection
Bayer AGBayer AG – FDA Inspection, Oct 10, 2019
Record Details
This FDA Inspection record concerns Bayer AG, with an inspection on October 10, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bayer AG
- Inspection Date
- October 10, 2019
- Product Type
- Drugs
View Company Profile
ID · 21e6c9af-685c-4f17-a41a-37c5e0ef33ce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1126224
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bayer AG
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 14, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 12, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 12, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bayer AG
- FDA Inspection 1282946 - 2024-11-14
- FDA Inspection 1062335 - 2018-06-15
- FDA Inspection 949853 - 2015-11-12
- FDA Inspection 837370 - 2013-05-24
- FDA Inspection 651516 - 2010-02-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.